Hiroki Komatsuda

12PUBLICATIONS
17CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 10, 2026
Peptide-Reactive T-cell Response as a Novel Biomarker in Patients with Head and Neck Cancer Treated with Anti-PD-1 Antibody.

|Jul 29, 2025
ROR1 as an Immunotherapeutic Target for Inducing Antitumor Helper T Cell Responses Against Head and Neck Squamous Cell Carcinoma.

Ryosuke Sato, Hidekiyo Yamaki, Takahiro Inoue

|Sep 14, 2024
Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer.

Risa Wakisaka, Hidekiyo Yamaki, Michihisa Kono

|Mar 28, 2024
Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers.

Ryosuke Sato, Hidekiyo Yamaki, Hiroki Komatsuda

|Jan 27, 2024
Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma.

Toshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi

|Jan 22, 2024
Harnessing Immunity to Treat Advanced Thyroid Cancer.

Hiroki Komatsuda, Michihisa Kono, Risa Wakisaka

Pageof 2

Frequent Collaborators

12 joint publications

Takumi Kumai

6 joint publications

Ryosuke Sato

5 joint publications

Michihisa Kono

3 joint publications

Takayuki Ohkuri